TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biolin Scientific AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 118,087 | 106,935 | 90,579 |
Financial expenses | 463 | 244 | 411 |
Earnings before taxes | 20,775 | 15,071 | 12,271 |
EBITDA | 26,019 | 20,933 | 19,078 |
Total assets | 121,915 | 104,818 | 108,800 |
Current assets | 36,376 | 25,659 | 31,811 |
Current liabilities | 27,955 | 27,256 | 20,939 |
Equity capital | 93,137 | 76,796 | 66,834 |
- share capital | 26,581 | 26,581 | 26,581 |
Employees (average) | 21 | 23 | 19 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 76.4% | 73.3% | 61.4% |
Turnover per employee | 5,623 | 4,649 | 4,767 |
Profit as a percentage of turnover | 17.6% | 14.1% | 13.5% |
Return on assets (ROA) | 17.4% | 14.6% | 11.7% |
Current ratio | 130.1% | 94.1% | 151.9% |
Return on equity (ROE) | 22.3% | 19.6% | 18.4% |
Change turnover | 11,152 | 16,356 | -23,006 |
Change turnover % | 10% | 18% | -20% |
Chg. No. of employees | -2 | 4 | -1 |
Chg. No. of employees % | -9% | 21% | -5% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.